Filing Flows › Evolent Health (EVH) › Q1 2026
Evolent Health (EVH) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Evolent Health (EVH) reported revenue of $496M for the first quarter 2026 (Q1 2026), +3% from a year earlier and +6% from the quarter before. Operating margin was -2.1%, net loss $26.6M (5.4% of revenue).
Evolent Health, Q1 2026: revenue $496M (+3% year over year), operating margin -2.1%, net loss $26.6M, operating cash flow −$984K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $496M | +6% | +3% |
| Operating profit | −$10.6M | — | — |
| Net earnings | −$26.6M | — | — |
| Operating cash flow | −$984K | -102% | -122% |
What changed
Revenue was $496.2M in Q1 2026, up 3% year over year and up 6% from the previous quarter.
Operating costs exceeded revenue by $10.6M, an operating margin of -2.1%. Total costs grew 4% against revenue growth of 3%. The quarter ended with a net loss of $26.6M, narrower than the previous quarter's $429.1M loss. Net interest and other expense of $15.1M was the main reason.
Operating cash flow was −$1.0M. Non-cash charges added back $21.6M of depreciation and amortization and $10.6M of share-based compensation. Working capital and other items used $6.6M.
Questions
What was Evolent Health's revenue in the first quarter 2026?
Evolent Health (EVH) reported revenue of $496M for the first quarter 2026 (Q1 2026), +3% from a year earlier and +6% from the quarter before.
Was Evolent Health profitable in the first quarter 2026?
Operating loss was $10.6M (-2.1% of revenue) and net loss $26.6M.
Source: Evolent Health 10-Q on SEC EDGAR.